Inspire Medical Systems EU

Inspire Medical Systems EU is a medical technology company focused on developing and commercializing innovative solutions for obstructive sleep apnea (OSA). Founded in 2007 as a spin-out from Medtronic, the company specializes in neurostimulation technology that treats the root cause of OSA. Its flagship product, the Inspire system, is the first FDA-approved implantable device that stimulates the hypoglossal nerve to keep the airway open during sleep. Inspire has a strong presence in the United States and Europe, providing therapies for moderate to severe OSA. The Inspire Therapy involves a minimally invasive procedure to implant the device, which monitors breathing patterns and prevents airway collapse. The company also offers clinical support and education to optimize therapy outcomes. Inspire is committed to regulatory compliance, having maintained CE mark certification since 2010 and successfully transitioning to the updated EU Medical Device Regulation.

• Employees 18
• Founded 2007